Baader Bank Aktiengesellschaft purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 6,500 shares of the company's stock, valued at approximately $206,000. Baader Bank Aktiengesellschaft owned about 0.12% of Nutex Health at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in NUTX. Beaird Harris Wealth Management LLC bought a new position in Nutex Health during the 3rd quarter worth $69,000. International Assets Investment Management LLC bought a new position in shares of Nutex Health during the third quarter worth about $188,000. State Street Corp acquired a new stake in shares of Nutex Health in the 3rd quarter worth about $225,000. Thompson Davis & CO. Inc. acquired a new position in Nutex Health during the 3rd quarter valued at about $494,000. Finally, Drive Wealth Management LLC bought a new position in Nutex Health in the 4th quarter worth about $1,122,000. 5.32% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on NUTX. Maxim Group boosted their price objective on Nutex Health from $45.00 to $50.00 and gave the stock a "buy" rating in a research report on Tuesday, November 12th. Benchmark raised their price target on Nutex Health from $45.00 to $60.00 and gave the company a "buy" rating in a report on Tuesday, November 12th.
Read Our Latest Analysis on Nutex Health
Nutex Health Price Performance
NASDAQ:NUTX traded down $0.12 during trading hours on Tuesday, reaching $48.90. 26,265 shares of the company's stock were exchanged, compared to its average volume of 35,556. The company has a market capitalization of $265.99 million, a P/E ratio of -5.21 and a beta of 0.20. Nutex Health Inc. has a 12 month low of $4.16 and a 12 month high of $49.75. The business's 50-day simple moving average is $35.86 and its two-hundred day simple moving average is $25.84. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($1.72) earnings per share for the quarter. The business had revenue of $78.79 million for the quarter. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.
Nutex Health Profile
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Read More
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
